SCHEMBL23093483

SCHEMBL23093483

CCOC(=O)C(Cc1ccccc1C#N)(NC(C)=O)C(=O)OCC

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.62
▸ RECQL P46063 1/20 0.62
▸ MAPK1 P28482 1/20 0.49
▸ PKM P14618 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ ATM Q13315 2/20 0.47
▸ THRB P10828 2/20 0.47
▸ HTT P42858 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NLRP3 Q96P20 1/20 0.43
▸ TAAR1 Q96RJ0 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ TSHR P16473 2/20 0.40
▸ APP P05067 1/20 0.39
▸ MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7010560 0.87 PTPRB (0.47) ALDH1A1RECQLMAPK1KDM4EL3MBTL1
SCHEMBL5860010 0.81 ALDH1A1 (0.67) ALDH1A1RECQLMAPK1PKMKDM4E
SCHEMBL1686141 0.81 ALDH1A1 (0.67) ALDH1A1RECQLMAPK1PKMKDM4E
SCHEMBL4705070 0.81 ALDH1A1 (0.67) ALDH1A1RECQLMAPK1PKMKDM4E
SCHEMBL23004849 0.81 ALDH1A1 (0.67) ALDH1A1RECQLMAPK1PKMKDM4E
SCHEMBL16001113 0.81 ALDH1A1 (0.67) ALDH1A1RECQLMAPK1PKMKDM4E
SCHEMBL9849152 0.81 ALDH1A1 (0.67) ALDH1A1RECQLMAPK1PKMKDM4E
SCHEMBL18322486 0.80 ALDH1A1 (0.47) ALDH1A1RECQLKDM4EL3MBTL1GAA
SCHEMBL10624673 0.80 ALDH1A1 (0.65) ALDH1A1RECQLMAPK1PKMKDM4E
SCHEMBL27394284 0.79 ALDH1A1 (0.64) ALDH1A1RECQLMAPK1PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240262792-A1 USP30 INHIBITORS AND USES THEREOF VINCERE BIOSCIENCES, INC. 2024-08-08 — — US disclosed
US-11845724-B2 USP30 inhibitors and uses thereof VINCERE BIOSCIENCES, INC. (US) 2023-12-19 — — US disclosed
US-20220315531-A1 USP30 INHIBITORS AND USES THEREOF VINCERE BIOSCIENCES, INC. 2022-10-06 — — US disclosed
CN-115038688-A USP30 inhibitors and uses thereof 文森雷生物科学股份有限公司 2022-09-09 — — CN disclosed
EP-4028385-A1 USP30 INHIBITORS AND USES THEREOF Vincere Biosciences, Inc. (US) 2022-07-20 — — EP disclosed
WO-2021050992-A1 USP30 INHIBITORS AND USES THEREOF VINCERE BIOSCIENCES, INC. (US) 2021-03-18 — — WO disclosed
WO-2021050992-A1 USP30 INHIBITORS AND USES THEREOF VINCERE BIOSCIENCES, INC. (US) 2021-03-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11845724-B2 USP30 inhibitors and uses thereof USP30, USP28, USP1 ALDH1A1 2021/4885RECQL 1217/4885MAPK1 2205/4885
US-20220315531-A1 USP30 INHIBITORS AND USES THEREOF USP30, USP28, USP1 ALDH1A1 2021/4885RECQL 1217/4885MAPK1 2205/4885
US-20240262792-A1 USP30 INHIBITORS AND USES THEREOF USP30, USP28, USP1 ALDH1A1 2021/4885RECQL 1217/4885MAPK1 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback